In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine

被引：0
|
作者：
Anand Joshi
Brian F. Kiesel
Nupur Chaphekar
Reyna Jones
Jianxia Guo
Charles A. Kunos
Sarah Taylor
Edward Chu
Raman Venkataramanan
Jan H. Beumer
机构：
[1] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[2] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[3] National Cancer Institute,Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis
[4] University of Pittsburgh-Magee Women’s Hospital,Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Triapine; Metabolism; Drug–drug interaction; CYP450; Metabolic pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [31] Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes
    Demir, Yeliz
    Taslimi, Parham
    Ozaslan, Muhammet Serhat
    Oztaskin, Necla
    Cetinkaya, Yasin
    Gulcin, Ilhami
    Beydemir, Sukru
    Goksu, Suleyman
    ARCHIV DER PHARMAZIE, 2018, 351 (12)
  • [32] In vitro evaluation of doravirine potential for pharmacokinetic drug interactions
    Sanchez, Rosa I.
    Fillgrove, Kerry
    Hafey, Michael
    Palamanda, Jairam
    Newton, Deborah
    Lu, Bing
    Bleasby, Kelly
    DRUG METABOLISM REVIEWS, 2016, 48 : 73 - 73
  • [33] IN VITRO CHARACTERIZATION OF DRUG METABOLIZING ENZYMES AND TRANSPORTERS TO ENABLE A MECHANISTIC DRUG-DRUG INTERACTION ASSESSMENT FOR VENETOCLAX
    Kikuchi, Ryota
    Shebley, Mohamad
    Bow, Daniel A. J.
    Carr, Robert A.
    Nijsen, Marjoleen
    de Morais, Sonia M.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S51 - S51
  • [34] In vitro metabolism of indiplon and an assessment of its drug interaction potential
    Madan, A.
    Fisher, A.
    Jin, L.
    Chapman, D.
    Bozigian, H. P.
    XENOBIOTICA, 2007, 37 (07) : 736 - 752
  • [35] Limitations of In Vitro Assessments of the Drug Interaction Potential of Botanical Supplements
    Markowitz, John S.
    Zhu, Hao-Jie
    PLANTA MEDICA, 2012, 78 (13) : 1421 - 1427
  • [36] Limitations of in vitro assessments of the drug interaction potential of botanical supplements
    Markowitz, J. S.
    PLANTA MEDICA, 2015, 81 (16) : 1395 - 1395
  • [37] Analysis and Evaluation of Potential Drug-Drug Interaction in the Meningitis Therapy
    Farmanullah
    Ullah, Irfan
    Izharullah
    Dar, Eshwa
    Alahmadi, Yaser M.
    Iqbal, Muhammad Omer
    Shaikh, Abdul Rasheed
    Sohail, Kashif
    Khan, Haroon
    Ahmed, Tahseen
    Parveen, Shumaila
    Alolayan, Sultan Othman
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (06): : 1315 - 1318
  • [38] Animal Models for Evaluation of Drug-Drug Interaction Potential of Biotherapeutics
    Kraynov, Eugenia
    Dowty, Martin E.
    Fahmi, Odette A.
    Fields, Owen
    CURRENT DRUG METABOLISM, 2012, 13 (07) : 947 - 950
  • [39] Evaluation of a potential tigecycline-warfarin drug interaction
    Zimmerman, James J.
    Raible, Donald G.
    Harper, Dawn M.
    Matschke, Kyle
    Speth, John L.
    Korth-Bradley, Joan M.
    PHARMACOTHERAPY, 2008, 28 (07): : 895 - 905
  • [40] An evaluation of the drug interaction potential of netupitant with digoxin.
    Baumann, Sybille
    Tilola, Silvia Olivari
    Spinelli, Tulla
    Timmer, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345